Sigma-Aldrich Corp. has acquired Molecular Medicine BioServices Inc., a biopharma CMO located in Carlsbad, CA, to enhance the biologics capabilities within its SAFC Pharma business segment. The acquisition of MMB, which had $12 million in revenues last year, is expected to help Sigma-Aldrich “achieve its growth goals in key high technology markets over the next several years,” according to the company. David Backer, president of MMB, an equity holder and one of the company’...